Budget Impact Analysis of EGFR Mutation Liquid Biopsy for First- and Second-Line Treatment of Metastatic Non-Small Cell Lung Cancer in Greece

Within the European Union, Greece has the highest incidence of lung cancer among people under 45 years of age. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors are indicated for the treatment of patients with EGFR mutation-positive metastatic non-small cell lung cancer (mNSCLC). Tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Mindy, Akalestos, Athanasios, Scudder, Sidney
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345049/
https://www.ncbi.nlm.nih.gov/pubmed/32599934
http://dx.doi.org/10.3390/diagnostics10060429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345049/
https://www.ncbi.nlm.nih.gov/pubmed/32599934
http://dx.doi.org/10.3390/diagnostics10060429

Ejemplares similares